|
FAM108B1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.8742999998791E-07 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.462500E-02 |
| Normal-vs-Stage2 |
6.799500E-03 |
| Normal-vs-Stage3 |
7.58660000377276E-08 |
| Normal-vs-Stage4 |
2.52709997372591E-09 |
| Stage1-vs-Stage2 |
1.421190E-01 |
| Stage1-vs-Stage3 |
7.571900E-04 |
| Stage1-vs-Stage4 |
2.00419999999424E-05 |
| Stage2-vs-Stage3 |
3.666200E-01 |
| Stage2-vs-Stage4 |
1.482010E-01 |
| Stage3-vs-Stage4 |
3.815600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.34100000004356E-06 |
| Normal-vs-AfricanAmerican |
4.875700E-03 |
| Normal-vs-Asian |
3.789000E-01 |
| Caucasian-vs-AfricanAmerican |
9.803000E-01 |
| Caucasian-vs-Asian |
5.440800E-01 |
| AfricanAmerican-vs-Asian |
5.426600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.85240001115972E-09 |
| Normal-vs-Female |
9.145800E-02 |
| Male-vs-Female |
8.37210000000921E-05 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.750200E-02 |
| Normal-vs-Age(41-60Yrs) |
1.395910E-03 |
| Normal-vs-Age(61-80Yrs) |
1.31740000020031E-07 |
| Normal-vs-Age(81-100Yrs) |
9.535100E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.086000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.183200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.875200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.560100E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.711800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.554800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.497000E-01 |
| Normal-vs-Grade 2 |
5.183600E-02 |
| Normal-vs-Grade 3 |
6.49770004468309E-09 |
| Normal-vs-Grade 4 |
2.16637818795107E-12 |
| Grade 1-vs-Grade 2 |
6.193700E-02 |
| Grade 1-vs-Grade 3 |
9.67269999999631E-05 |
| Grade 1-vs-Grade 4 |
1.184260E-03 |
| Grade 2-vs-Grade 3 |
1.624460E-04 |
| Grade 2-vs-Grade 4 |
4.30489999203587E-09 |
| Grade 3-vs-Grade 4 |
3.479700E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
7.263200E-01 |
| Normal-vs-ccB subtype |
1.79690040624791E-10 |
| ccA subtype-vs-ccB subtype |
5.53330048447265E-10 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.203400E-04 |
| Normal-vs-N1 |
6.48560000038323E-07 |
| N0-vs-N1 |
3.481600E-02 |
|
|
